Table 3.
Age-adjusted mortality per 1,000 years
| HDL (mg/dl) | Female Estimate (95% CI) | Male Estimate (95% CI) |
|---|---|---|
| All-cause | ||
| ≤30 | 110 (99, 122) | 89 (83, 96) |
| 31–40 | 56 (52, 60) | 58 (55, 62) |
| 41–50 | 46 (44, 49) | 52 (49, 55) |
| 51–60 | 40 (38, 43) | 52 (49, 56) |
| ≥60 | 36 (34, 38) | 56 (52, 61) |
| Cardiovascular | ||
| ≤30 | 40 (34, 47) | 35 (31, 39) |
| 31–40 | 18 (16, 20) | 23 (21, 25) |
| 41–50 | 15 (14, 16) | 19 (17, 21) |
| 51–60 | 13 (11, 14) | 17 (15, 19) |
| ≥60 | 12 (11, 13) | 18 (16, 20) |
| Malignancy | ||
| ≤30 | 21 (17, 27) | 21 (18, 25) |
| 31–40 | 12 (11, 15) | 14 (12, 16) |
| 41–50 | 10 (9, 11) | 12 (11, 13) |
| 51–60 | 9 (8, 11) | 13 (11, 15) |
| ≥60 | 8 (7, 9) | 13 (11, 16) |
| Non-cardiovascular non-malignancy | ||
| ≤30 | 44 (38, 52) | 30 (27, 35) |
| 31–40 | 23 (21, 26) | 18 (17, 20) |
| 41–50 | 19 (17, 21) | 19 (18, 21) |
| 51–60 | 16 (15, 18) | 21 (18, 23) |
| ≥60 | 15 (14, 16) | 23 (20, 26) |
Mortality rates adjusted to mean age of 72 for females, and mean age of 71 for males